Cargando…
Functional convalescent plasma antibodies and pre-infusion titers shape the early severe COVID-19 immune response
Transfer of convalescent plasma (CP) had been proposed early during the SARS-CoV-2 pandemic as an accessible therapy, yet trial results worldwide have been mixed, potentially due to the heterogeneous nature of CP. Here we perform deep profiling of SARS-CoV-2-specific antibody titer, Fc-receptor bind...
Autores principales: | Herman, Jonathan D., Wang, Chuangqi, Loos, Carolin, Yoon, Hyunah, Rivera, Johanna, Eugenia Dieterle, M., Haslwanter, Denise, Jangra, Rohit K., Bortz, Robert H., Bar, Katharine J., Julg, Boris, Chandran, Kartik, Lauffenburger, Douglas, Pirofski, Liise-anne, Alter, Galit |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8617042/ https://www.ncbi.nlm.nih.gov/pubmed/34824251 http://dx.doi.org/10.1038/s41467-021-27201-y |
Ejemplares similares
-
Functional Antibodies in COVID-19 Convalescent Plasma
por: Herman, Jonathan D., et al.
Publicado: (2021) -
Nucleocapsid-specific antibody function is associated with therapeutic benefits from COVID-19 convalescent plasma therapy
por: Herman, Jonathan D., et al.
Publicado: (2022) -
COVID-19 convalescent plasma therapy through the lens of the third year of the pandemic
por: Pirofski, Liise-anne
Publicado: (2023) -
Rethinking the role of COVID-19 convalescent plasma in the critically ill
por: Casadevall, Arturo, et al.
Publicado: (2023) -
A Replication-Competent Vesicular Stomatitis Virus for Studies of SARS-CoV-2 Spike-Mediated Cell Entry and Its Inhibition
por: Dieterle, M. Eugenia, et al.
Publicado: (2020)